Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome

In Vivo and In Vitro Inhibition of Monocyte Adhesion to Endothelial Cells and Endothelial Adhesion Molecules by Eicosapentaenoic Acid

(2008) Hideto Yamada et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives

(2008) William S. Harris et al.   ATHEROSCLEROSIS

A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome

(2008) Kazuhiko Kotani et al.   ATHEROSCLEROSIS

Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure

(2008) Junko Ibata et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Evaluation of the Cardio-Ankle Vascular Index, a New Indicator of Arterial Stiffness Independent of Blood Pressure, in Obesity and Metabolic Syndrome

(2008) Noriko Satoh et al.   HYPERTENSION RESEARCH

Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome

(2008) Paul Holvoet   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice

(2007) Miwa Matsumoto et al.   ATHEROSCLEROSIS